Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non–Small-Cell Lung Cancer

Authors: Gelatti, Ana C.Z., Cordeiro de Lima, Vladmir C., Freitas, Helano, Werutsky, Gustavo, Gaiger, Ana Maria, Klock, Clovis, Viola, Patricia P., Shiang, Christina, de Macedo, Mariana P., Lopes, Lisandro F., De Marchi, Pedro, Albino da Silva, Eduardo Caetano, Moura, Fernando, Borges, Giuliano, Zaffaroni, Facundo, Nunes Filho, Paulo Ricardo, Araujo, Luiz H., Mascarenhas, Eldsamira, Mathias, Clarissa, Barrios, Carlos, Zukin, Mauro

Source: In Clinical Lung Cancer November 2020 21(6):e511-e515

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

Authors: Gelatti, Ana C.Z., Drilon, Alexander, Santini, Fernando C.

Source: In Lung Cancer November 2019 137:113-122